Skip to content

Transfacial Sutures Versus Stapler for Mesh Fixation in Laparoscopic Ventral Hernia Repair

Mesh Shrinkage Following Transfacial Suturing Versus Stapler for Mesh Fixation in Laparoscopic Ventral Hernia Repair: a Prospective, Randomised Blinded Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00773851
Enrollment
36
Registered
2008-10-16
Start date
2005-04-30
Completion date
2008-10-31
Last updated
2023-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Ventral Hernia

Keywords

ventral hernia, laparoscopy, mesh, recurrence

Brief summary

Hernia of the abdominal wall occur frequently after various surgical procedures of the abdomen and are increasingly performed by laparoscopic means. Different mesh fixation techniques are applied, but the influence of mesh fixation on shrinkage is not known in human patients. Therefore, mesh shrinkage was assessed using two different techniques for fixation.

Detailed description

Ventral hernia repair is increasingly performed by laparoscopic means. While mesh ingrowth and shrink-age has been analysed in the experimental setting, there is scarce data available in humans. In addition, different mesh fixation techniques are applied, but the influence of mesh fixation on shrinkage is not known in human patients. Mesh shrinkage is assessed using two different techniques for fixation. Blinded randomized trial using a Parietene composite mesh for laparoscopic ventral hernia repair. Patients with ventral hernias of no larger than 8 cm were assigned to either mesh fixation using transfacial nonabsorbable sutures or titan tacks. Primary endpoint was mesh migration, secondary endpoints were mesh shrinkage, surgical morbidity and pain.

Interventions

mesh fixation by staples

PROCEDUREmesh fixation by transfacial sutures

mesh fixation by transfacial sutures

Sponsors

Sofradim Production
CollaboratorINDUSTRY
Medtronic - MITG
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with incisional hernia smaller than 8cm in diameter * obtained informed consent

Exclusion criteria

* Pregnancy * Residual intraperitoneal mesh * contaminated abdominal cavity * longterm use of corticosteroids and other immunosuppressive agents * bodymass index \> 45 * general contradictions for laparoscopy

Design outcomes

Primary

MeasureTime frame
mesh shrinkageperioperative, 6 weeks, 6 months postoperative

Secondary

MeasureTime frame
mesh dislocationperioperative, 6 weeks postoperative,6 months postoperative
painperioperative, 6 weeks postoperative,6 months, 12 moths postoperative
recurrenceperioperative, 6 weeks postoperative,6 months, 12 months postoperative

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026